News

Panel supports lower doses of novel insomnia drug


 

FROM AN FDA ADVISORY PANEL MEETING

Panelists have been cleared of potential conflicts of interest related to the topic of the meeting. Occasionally, a panelist may be given a waiver, but not at this meeting.

emechcatie@frontlinemedcom.com

Pages

Recommended Reading

2011 FDA Approvals
MDedge ObGyn